文献速递心血管胸部CT

CT衍生心肌生物标志物对接受经导管主动脉瓣置换术的重度主动脉瓣狭窄患者的预后价值:细胞外容积分数与应变的系统评价与Meta分析

Prognostic Value of CT-Derived Myocardial Biomarkers: Extracellular Volume Fraction and Strain in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis.
PubMed 文献 · Acad Radiol · 2024-06-21

该系统评价与Meta分析检索了PubMed、Web of Science和Embase三个数据库(2024年4月),纳入11项研究,评估术前CT衍生心肌生物标志物(细胞外容积分数ECV和左心室整体纵向应变LVGLS)对接受经导管主动脉瓣置换术(TAVR)的重度主动脉瓣狭窄患者的预后价值。Meta分析显示,ECV(二分类变量汇总HR 3.87,95%CI 2.63-5.70,I²=0%;连续变量汇总HR 1.12,95%CI 1.05-1.19,I²=66%)和LVGLS(二分类变量汇总HR 1.70,95%CI 1.30-2.22,I²=0%;连续变量汇总HR 1.07,95%CI 1.04-1.10,I²=0%)均为显著预测因子。结论认为较高的CT衍生ECV和受损的LVGLS能够预测接受TAVR的重度AS患者更差的结局。

要点

  • CT衍生ECV(二分类变量汇总HR 3.87,95%CI 2.63-5.70)和LVGLS(二分类变量汇总HR 1.70,95%CI 1.30-2.22)均可预测TAVR术后不良结局。
  • ECV和LVGLS作为连续变量时亦为显著预测因子(ECV汇总HR 1.12,95%CI 1.05-1.19;LVGLS汇总HR 1.07,95%CI 1.04-1.10)。
  • 年龄、性别、随访时间和平均压差对ECV(连续变量)模型有显著影响。

核心结论

  • 较高的CT衍生ECV和受损的LVGLS能够预测接受TAVR的重度AS患者更差的结局。

研究设计与样本

  • 系统评价与Meta分析,2024年4月检索PubMed、Web of Science和Embase三个数据库,纳入11项研究。
  • 其中6项研究共678例患者报告ECV,1项研究300例患者报告ECV和LVGLS,3项研究共868例患者报告LVGLS,1项研究376例患者报告LVGLS和峰值左房纵向应变(PALS)。
  • 采用随机效应模型计算汇总风险比(HR)和95%置信区间(CI),用I²统计量评估异质性,并进行Meta回归分析。
  • 终点包括全因死亡率、主要不良心血管事件(MACE)及上述两者的复合结局。

诊断标准与关键数值

  • ECV作为二分类变量:汇总HR 3.87(95%CI 2.63-5.70,I²=0%),为显著预测因子。
  • ECV作为连续变量:汇总HR 1.12(95%CI 1.05-1.19,I²=66%),为显著预测因子。
  • LVGLS作为二分类变量:汇总HR 1.70(95%CI 1.30-2.22,I²=0%),为显著预测因子。
  • LVGLS作为连续变量:汇总HR 1.07(95%CI 1.04-1.10,I²=0%),为显著预测因子。

临床应用与阅片要点

  • 作者结论认为CT衍生ECV和LVGLS可用于预测接受TAVR的重度AS患者的不良结局。

局限性

  • ECV作为连续变量时异质性I²=66%。
  • 年龄、性别、随访时间和平均压差对ECV(连续变量)模型有显著影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: This study aimed to investigate the prognostic value of preoperative CT scan-derived myocardial biomarkers in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR).

MATERIALS AND METHODS: In April 2024, three databases (PubMed, Web of Science and Embase) were searched to identify studies. A random-effects model for meta-analysis was conducted to calculate pooled hazard ratios (HR) and 95% confidence intervals (CI) to assess the prognostic value. The I2 statistic was used to assess heterogeneity. Meta-regression analysis was conducted to appraise which variables yielded a significant impact on the HR of included biomarkers.

RESULTS: 11 studies were identified, of which six studies involved 678 patients reporting extracellular volume fraction (ECV), one study involved 300 patients reporting ECV and left ventricular global longitudinal strain (LVGLS), three studies involved 868 patients reporting LVGLS and one study involved 376 patients reporting LVGLS and peak left atrial longitudinal strain (PALS). The endpoints included all-cause mortality, major adverse cardiovascular events (MACE) and a composite outcome of the previous two. The meta-analysis revealed that ECV, whether considered as a dichotomous variable (pooled HR: 3.87, 95% CI: 2.63-5.70, I2 = 0%), or as a continuous variable (pooled HR: 1.12, 95% CI: 1.05-1.19, I2 = 66%), and LVGLS, whether considered as a dichotomous variable (pooled HR: 1.70, 95% CI: 1.30-2.22, I2 = 0%) or a continuous variable (pooled HR: 1.07, 95% CI: 1.04-1.10, I2 = 0%) were all significant predictors for outcomes in patients with severe AS after TAVR. Age, sex, follow-up time and mean pressure gradient had a significant impact on the model of ECV (continuous).

CONCLUSION: The higher CT-derived ECV and impaired LVGLS are able to predict worse outcomes in patients with severe AS who have undergone TAVR.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. He X, Li Y, Wang Y, et al. Prognostic Value of CT-Derived Myocardial Biomarkers: Extracellular Volume Fraction and Strain in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis. Acad Radiol. 2024. PMID: 38906780. doi:10.1016/j.acra.2024.06.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。